5,898 followers
New Research: Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer https://t.co/hd7Ni2LkuN #pharmacology
New Research: Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer https://t.co/hd7Ni2LkuN #pharmacology